Knowledge Tree
Relations (1)
related 2.32 — strongly supporting 4 facts
Depression and substance use disorders are linked as common targets for psychedelic therapy research [1] and are both associated with positive outcomes from peak mystical experiences [2]. Furthermore, they frequently co-occur with other conditions [3] and are both effectively treated using Cognitive Behavioral Therapy (CBT) [4].
Facts (4)
Sources
Ancient Roots of Today's Emerging Renaissance in ... link.springer.com 1 fact
claimPeer-reviewed research has established the preliminary effectiveness of psychedelic therapies in treating depression (Carhart-Harris et al. 2021; Davis et al. 2020), substance use disorders (Bogenschutz et al. 2015; Johnson et al. 2014), PTSD (Mitchell et al. 2021), and anxiety for patients facing terminal cancer (Griffiths et al. 2016; Grob et al. 2011; Ross et al. 2016).
Overview of Anxiety Disorders - Psychiatry - MSD Manuals msdmanuals.com 1 fact
claimAnxiety disorders frequently co-occur with depression, substance use disorders, personality disorders, cardiovascular disease, asthma, migraines, and arthritis.
CBT For Generalized Anxiety Disorder (GAD) cogbtherapy.com 1 fact
claimCognitive Behavioral Therapy (CBT) is considered the most effective treatment for mental health disorders including substance use disorder, obsessive-compulsive disorder (OCD), depression, and other psychological difficulties.
Medicinal plants meet modern biodiversity science - OUCI ouci.dntb.gov.ua 1 fact
claimNumerous studies indicate a direct correlation between the strength of peak and mystical experiences and positive, long-lasting psychological outcomes in psychedelic psychotherapy for conditions including depression, cancer-related distress, and substance use disorders.